Introduction
The worldwide biopharmaceutical excipients industry is analysed to grow with 6.9% CAGR in forthcoming years and the market is predicted to reach USD 3.3 billion by 2026.
Market Dynamics
The steadiness of large molecules is naturally less, when contrasted with little particles. Research and investments made to address the difficulties saw as a consequence of aforementioned fact are relied upon to drive the market in future. Rewarding development of the biopharmaceutical business has made potential opportunity for the conventional drug excipient developers to extend their business activities in this market.
Rapid development of the biopharmaceutical business because of expanding manufacturing capacities is one of the key main impetus of this market. Increase in the quantity of protein therapeutics combined with the presence of a considerable number of excipients to shield these proteins from debasement is additionally driving the market development.
Market Insights
Investigational studies about that are executed for the effect examination of excipient variability on in vitro disintegration testing are projected to lessen the attrition rate of definite products and increment the reproducibility. These investigations help researchers in picking up bits of knowledge on the in vivo working and pharmacodynamic examination of extensive atoms. The market displays constant need of inventive excipient advances to drag out the in vivo viability of biologics and for development in the item conveyance. Also, broad R&D for the advancement of crude materials that assistance enhance yields in mammalian cell-culture forms is required to drive the market in future.
Carbohydrates, especially sucrose, starch, and dextrose drove the market previously and represented the biggest offer in worldwide revenue. Easy accessibility of products at sensible costs has brought about wide use of sucrose as a building and balancing out operator in about 80% of the lyophilized monoclonal counter acting agent based definitions. Also, starch is as a rule customarily utilized in various medication products inferable from its well-defined safety profile. It very well may be changed to grow its properties, which further guides in the detailing of complex delivery systems for large molecules.
Market Segmentation
Market By Product
- Solubilizers& Surfactants/Emulsifiers
- Triglycerides
- Esters
- Others
- Polyols
- Carbohydrates
- Sucrose
- Dextrose
- Starch
- Others
- Specialty Biopharmaceutical Excipients/Others
Market By Geography
- North America
- Europe
- UK
- Germany
- France
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- Rest of Asia-Pacific
- Latin America
- Brazil
- Chile
- Rest of Latin America
- Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- Rest of MEA
Regional Insights
Europe represented the biggest offer of the worldwide market in 2018, trailed by North America. Presence of enhanced providers and strong research financing in chemicals division has come about into the evaluated offer of these areas in worldwide revenue. Development prospects for this industry in these business sectors are anticipated to be moderate in the coming years.
Developing markets, for example, India, China, and South Korea, are anticipated to observe worthwhile development. The foreseen increase in demand after and sales for raw materials in these business sectors, can be credited to the developing biopharmaceutical industry and extending business impression of organizations in the Asian nations.
Market Participants
The key companies catering in the global biopharmaceutical excipients market are BASF SE; ABITEC Corp.; Spectrum Chemical Manufacturing Corp; Signet Chemical Corporation Pvt. Ltd.; Pharmonix Biological Pvt. Ltd.;., Roquette; SPI Pharma; Sigachi Industries Pvt. Ltd.; IMCD; Meggle AG; Clariant; Colorcon, Inc.; and DFE Pharma.
CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
1.1.1. Definition of Biopharmaceutical Excipients
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Biopharmaceutical Excipients Market By Product
1.2.2.1. Global Biopharmaceutical Excipients Market Revenue and Growth Rate Comparison By Product (2015-2026)
1.2.2.2. Global Biopharmaceutical Excipients Market Revenue Share By Product in 2017
1.2.2.3. Solubilizers& Surfactants/Emulsifiers
1.2.2.4. Polyols
1.2.2.5. Carbohydrates
1.2.2.6. Specialty Biopharmaceutical Excipients
1.2.2.7. Others
1.2.3. Biopharmaceutical Excipients Market by Geography
1.2.3.1. Global Biopharmaceutical Excipients Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.3.2. North America Biopharmaceutical Excipients Market Revenue and Growth Rate (2015-2026)
1.2.3.3. Europe Biopharmaceutical Excipients Market Revenue and Growth Rate (2015-2026)
1.2.3.4. Asia-Pacific Biopharmaceutical Excipients Market Revenue and Growth Rate (2015-2026)
1.2.3.5. Latin America Biopharmaceutical Excipients Market Revenue and Growth Rate (2015-2026)
1.2.3.6. Middle East and Africa (MEA) Biopharmaceutical Excipients Market Revenue and Growth Rate (2015-2026)
CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players
CHAPTER 3. MANUFACTURING PLANTS ANALYSIS
3.1. Capacity and Commercial Production Date of Global Biopharmaceutical Excipients Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Biopharmaceutical Excipients Major Manufacturers in 2017
3.3. R&D Status and Technology Source of Global Biopharmaceutical Excipients Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Biopharmaceutical Excipients Major Manufacturers in 2017
CHAPTER 4. BIOPHARMACEUTICAL EXCIPIENTS MARKET BY PRODUCT
4.1. Global Biopharmaceutical Excipients Revenue By Product
4.2. Solubilizers& Surfactants/Emulsifiers
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Polyols
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Carbohydrates
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.5. Specialty Biopharmaceutical Excipients
4.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.6. Others
4.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
CHAPTER 5. NORTH AMERICA BIOPHARMACEUTICAL EXCIPIENTS MARKET BY COUNTRY
5.1. North America Biopharmaceutical Excipients Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2. North America Biopharmaceutical Excipients Market Revenue Share Comparison, 2015 & 2026 (%)
5.3. U.S.
5.3.1. U.S. Biopharmaceutical Excipients Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
5.4. Canada
5.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
5.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
5.5. Mexico
5.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
5.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
CHAPTER 6. EUROPE BIOPHARMACEUTICAL EXCIPIENTS MARKET BY COUNTRY
6.1. Europe Biopharmaceutical Excipients Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2. Europe Biopharmaceutical Excipients Market Revenue Share Comparison, 2015 & 2026 (%)
6.3. UK
6.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
6.4. Germany
6.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
6.5. France
6.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
6.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
6.6. Spain
6.6.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
6.6.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
6.7. Rest of Europe
6.7.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
6.7.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
CHAPTER 7. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET BY COUNTRY
7.1. Asia-Pacific Biopharmaceutical Excipients Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. Asia-Pacific Biopharmaceutical Excipients Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. China
7.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.4. Japan
7.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.5. India
7.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.6. Australia
7.6.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.6.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.7. South Korea
7.7.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.7.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.8. Rest of Asia-Pacific
7.8.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.8.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
CHAPTER 8. LATIN AMERICA BIOPHARMACEUTICAL EXCIPIENTS MARKET BY COUNTRY
8.1. Latin America Biopharmaceutical Excipients Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Latin America Biopharmaceutical Excipients Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. Brazil
8.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.4. Argentina
8.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.5. Rest of Latin America
8.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
CHAPTER 9. MIDDLE EAST BIOPHARMACEUTICAL EXCIPIENTS MARKET BY COUNTRY
9.1. Middle East Biopharmaceutical Excipients Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Middle East Biopharmaceutical Excipients Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. Saudi Arabia
9.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.4. UAE
9.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.5. Rest of Middle East
9.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
CHAPTER 10. AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET BY COUNTRY
10.1. Africa Biopharmaceutical Excipients Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Africa Biopharmaceutical Excipients Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. South Africa
10.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.4. Egypt
10.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.5. Rest of Africa
10.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
CHAPTER 11. COMPANY PROFILE
11.1. BASF SE
11.1.1. Company Snapshot
11.1.2. Overview
11.1.3. Financial Overview
11.1.4. Product Portfolio
11.1.5. Key Developments
11.1.6. Strategies
11.2. ABITEC Corp.
11.2.1. Company Snapshot
11.2.2. Overview
11.2.3. Financial Overview
11.2.4. Product Portfolio
11.2.5. Key Developments
11.2.6. Strategies
11.3. Spectrum Chemical Manufacturing Corp
11.3.1. Company Snapshot
11.3.2. Overview
11.3.3. Financial Overview
11.3.4. Product Portfolio
11.3.5. Key Developments
11.3.6. Strategies
11.4. Signet Chemical Corporation Pvt. Ltd.
11.4.1. Company Snapshot
11.4.2. Overview
11.4.3. Financial Overview
11.4.4. Product Portfolio
11.4.5. Key Developments
11.4.6. Strategies
11.5. Pharmonix Biological Pvt. Ltd.
11.5.1. Company Snapshot
11.5.2. Overview
11.5.3. Financial Overview
11.5.4. Product Portfolio
11.5.5. Key Developments
11.5.6. Strategies
11.6. Roquette
11.6.1. Company Snapshot
11.6.2. Overview
11.6.3. Financial Overview
11.6.4. Product Portfolio
11.6.5. Key Developments
11.6.6. Strategies
11.7. SPI Pharma
11.7.1. Company Snapshot
11.7.2. Overview
11.7.3. Financial Overview
11.7.4. Product Portfolio
11.7.5. Key Developments
11.7.6. Strategies
11.8. Sigachi Industries Pvt. Ltd.
11.8.1. Company Snapshot
11.8.2. Overview
11.8.3. Financial Overview
11.8.4. Product Portfolio
11.8.5. Key Developments
11.8.6. Strategies
11.9. IMCD
11.9.1. Company Snapshot
11.9.2. Overview
11.9.3. Financial Overview
11.9.4. Product Portfolio
11.9.5. Key Developments
11.9.6. Strategies
11.10. Meggle AG
11.10.1. Company Snapshot
11.10.2. Overview
11.10.3. Financial Overview
11.10.4. Product Portfolio
11.10.5. Key Developments
11.10.6. Strategies
11.11. Clariant
11.11.1. Company Snapshot
11.11.2. Overview
11.11.3. Financial Overview
11.11.4. Product Portfolio
11.11.5. Key Developments
11.11.6. Strategies
11.12. Colorcon, Inc.
11.12.1. Company Snapshot
11.12.2. Overview
11.12.3. Financial Overview
11.12.4. Product Portfolio
11.12.5. Key Developments
11.12.6. Strategies
11.13. DFE Pharma
11.13.1. Company Snapshot
11.13.2. Overview
11.13.3. Financial Overview
11.13.4. Product Portfolio
11.13.5. Key Developments
11.13.6. Strategies
11.14. Others
11.14.1. Company Snapshot
11.14.2. Overview
11.14.3. Financial Overview
11.14.4. Product Portfolio
11.14.5. Key Developments
11.14.6. Strategies
CHAPTER 12. RESEARCH APPROACH
12.1. Research Methodology
12.1.1. Initial Data Search
12.1.2. Secondary Research
12.1.3. Primary Research
12.2. Assumptions and Scope
![Biopharmaceutical Excipients Market (By Product: Solubilizers& Surfactants/Emulsifiers [Triglycerides, Esters, Others], Polyols [Mannitol, Sorbitol, Others], Carbohydrates [Sucrose, Dextrose, Starch, Others], Specialty Biopharmaceutical Excipients/Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026](assets/images/format-png.png "Biopharmaceutical Excipients Market (By Product: Solubilizers& Surfactants/Emulsifiers [Triglycerides, Esters, Others], Polyols [Mannitol, Sorbitol, Others], Carbohydrates [Sucrose, Dextrose, Starch, Others], Specialty Biopharmaceutical Excipients/Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026")
